Drug Profile
DHG
Alternative Names: depolymerised holothuria glycosaminoglycanLatest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Anticoagulants
- Mechanism of Action Glycosaminoglycan stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Deep vein thrombosis; Disseminated intravascular coagulation